"Epitope Mapping" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry.
| Descriptor ID |
D018604
|
| MeSH Number(s) |
E05.478.274 E05.601.690.300
|
| Concept/Terms |
Epitope Mapping- Epitope Mapping
- Epitope Mappings
- Mapping, Epitope
- Mappings, Epitope
|
Below are MeSH descriptors whose meaning is more general than "Epitope Mapping".
Below are MeSH descriptors whose meaning is more specific than "Epitope Mapping".
This graph shows the total number of publications written about "Epitope Mapping" by people in this website by year, and whether "Epitope Mapping" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 2 | 4 |
| 2005 | 1 | 7 | 8 |
| 2006 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 4 | 5 |
| 2016 | 0 | 1 | 1 |
| 2017 | 10 | 30 | 40 |
| 2018 | 7 | 24 | 31 |
| 2019 | 1 | 9 | 10 |
| 2020 | 2 | 13 | 15 |
| 2021 | 1 | 11 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Epitope Mapping" by people in Profiles.
-
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus. Int Immunopharmacol. 2021 Oct; 99:108020.
-
Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach. Clin Immunol. 2021 10; 231:108804.
-
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers. Nat Commun. 2021 06 16; 12(1):3661.
-
Cross-reactive antibody immunity against SARS-CoV-2 in children and adults. Cell Mol Immunol. 2021 07; 18(7):1826-1828.
-
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions. Cell Rep Med. 2021 06 15; 2(6):100313.
-
Immunoinformatics and Pepscan strategies on the path of a peptide-based serological diagnosis of COVID19. J Immunol Methods. 2021 08; 495:113071.
-
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells. Cell Rep. 2021 05 25; 35(8):109179.
-
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity. 2021 06 08; 54(6):1290-1303.e7.
-
Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody. Virus Res. 2021 07 15; 300:198445.
-
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients. Sci Immunol. 2021 04 14; 6(58).